Peak6 Llc
Source: SEC Form 13F · as of Mar 2026Peak6 Llc holds 14 biotech & pharma companies tracked by BioSniper, totaling $16.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$16.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 9,716 | $3.2M |
| MRNAModerna, Inc. | 60,583 | $3.1M |
| IONSIONIS PHARMACEUTICALS INC | 34,419 | $2.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,955 | $2.3M |
| INSMINSMED Inc | 7,926 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 7,597 | $1.1M |
| DNAGinkgo Bioworks Holdings Inc. | 107,163 | $657K |
| NKTRNEKTAR THERAPEUTICS | 7,000 | $504K |
| GPCRStructure Therapeutics Inc. | 6,055 | $292K |
| CLNNClene Inc. | 50,012 | $247K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 2,925 | $245K |
| OCULOCULAR THERAPEUTIX, INC | 26,656 | $226K |
| IMVTImmunovant, Inc. | 8,709 | $216K |
| QUREuniQure N.V. | 3,039 | $50K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.